Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

OBJECTIVE: To calculate sustainable generic prices for 4 tyrosine kinase inhibitors (TKIs). BACKGROUND: TKIs have proven survival benefits in the treatment of several cancers, including chronic myeloid leukaemia, breast, liver, renal and lung cancer. However, current high prices are a barrier to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Gotham, Dzintars, Fortunak, Joseph, Meldrum, Jonathan, Erbacher, Isabelle, Martin, Manuel, Shoman, Haitham, Levi, Jacob, Powderly, William G, Bower, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735306/
https://www.ncbi.nlm.nih.gov/pubmed/26817636
http://dx.doi.org/10.1136/bmjopen-2015-009586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735306/
https://www.ncbi.nlm.nih.gov/pubmed/26817636
http://dx.doi.org/10.1136/bmjopen-2015-009586

Ejemplares similares